Marco Rovaris
Papers
1
Total Citations
6
H-Index
1
About
Marco Rovaris is a leading figure in multiple sclerosis (MS) research, with a focus on neurorehabilitation, neural plasticity, and the complex interplay between disease-modifying therapies and opportunistic infections. His most cited work, a 2017 case study, demonstrates the remarkable efficacy of multidisciplinary rehabilitation in a 48-year-old MS patient who developed progressive multifocal leukoencephalopathy (PML) during natalizumab treatment. This landmark paper, garnering 6 citations, showed that intensive rehabilitation not only improved motor deficits but also induced measurable neural plasticity, challenging the assumption that PML precludes functional recovery. Rovaris’s contributions extend to understanding how aggressive MS therapies can be managed alongside severe complications, offering hope for patients with the most challenging clinical scenarios. His research bridges neurology and rehabilitation science, emphasizing that even in the face of devastating treatment-related adverse events, structured multidisciplinary care can drive meaningful neurological gains. Through this work, Rovaris has shaped clinical protocols for managing PML in MS and underscored the brain’s capacity for repair, making him a pivotal voice in optimizing long-term outcomes for patients with progressive neurological disease.
Research Focus
Key Achievements
Top Papers
- 1